Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Offers Jobs Courses Movies Merits
Sign In Sign Up
Theme Switcher
Night Mode
Sponsored
Advancements in Niemann-Pick Disease Type C Treatments: A Path Toward Better Outcomes
Zavesca (Miglustat): The Current Approved Therapy for Niemann-Pick Disease Type C Niemann-Pick Disease Type C (NPC) is a rare, progressive, and life-threatening lysosomal storage disorder marked by neurological and visceral complications. At present, Zavesca (miglustat), also sold as Brazaves, is the only approved therapy available for Niemann-Pick Type C treatment. Miglustat works by...
0 Comments ·0 Shares ·61 Views ·0 Reviews
Please log in to like, share and comment!
Sponsored
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade
Sponsored
Sponsored